VAIM Hosts ‘JULIA SUMMIT ASIA’ in Hong Kong, Advancing Academic Dialogue on Juvelook Across the Region

VAIM Hosts ‘JULIA SUMMIT ASIA’ in Hong Kong, Advancing Academic Dialogue on Juvelook Across the Region

On April 26, VAIM successfully held the ‘JULIA SUMMIT ASIA’ academic symposium in Hong Kong. The event brought together more than 150 key opinion leaders and physicians from 11 Asian countries, focusing on Juvelook’s clinical data, safety, and efficacy.

The summit highlighted the latest research on Juvelook’s safety and clinical outcomes, with particular emphasis on indications and protocols tailored to Asian skin types. Medical professionals from across the region shared real-world case studies and engaged in in-depth discussions on best practices to maximize safety and effectiveness.

The event also showcased advanced procedural trends and expertise from Korea, Juvelook’s largest global market. Participants demonstrated strong interest in the sophistication and precision of Korean aesthetic medicine, reaffirming Korea’s leadership in the Asian medical aesthetics field.

“JULIA SUMMIT ASIA went beyond product promotion, serving as a platform for academic exchange and the dissemination of best practices among healthcare professionals,” a VAIM representative stated. “We are committed to leading a culture of safe and effective procedures in the global market.”

The JULIA SUMMIT series will continue to be held in major regions worldwide, establishing itself as a premier global academic forum for sharing the scientific and clinical value of Juvelook.

Introduction of VAIM
Founded in 2014, VAIM is a global medical aesthetics company that develops human tissue regeneration products and improved pharmaceuticals by utilizing its accumulated technology and know-how in biocompatible and biodegradable polymers. It has developed and patented a PDLLA-based manufacturing technology that reduces the risk of nodule formation compared to other ingredient structures, and in 2019, its subsidiary, VAIM Global, entered the skin booster market with JUVELOOK, which utilizes this technology. JUVELOOK is a collagen booster that induces the production of ECM (collagen, elastin) to provide direct remodeling effects on the skin such as elasticity and wrinkle improvement, and is divided into JUVELOOK and LENISNA depending on the purpose. After quickly proving its safety and effectiveness since its launch, VAIM Global currently has product export contracts with 72 countries.